RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Nov. 8, 2005--Adherex Technologies Inc. (TSX:AHX)(AMEX:ADH), a biopharmaceutical company with a broad portfolio of oncology products under development, today announced that the Company will present data relevant to the market potential of ADH-1 (Exherin(TM)) during its presentation November 8, 2005 at 12:40 p.m. ET at the Rodman and Renshaw Techvest 7th Annual Healthcare Conference. The presentation will be webcast live and can be accessed by visiting the Company’s website at www.adherex.com. The same data will also be presented today during the Company’s presentation at BIOEurope 2005 in Dresden, Germany.
